Soft Tissue Allografts Market Scope And Analysis

  • Report Code : TIPRE00025025
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 165
Buy Now

Soft Tissue Allografts Market Growth Analysis by 2031

Buy Now

Soft Tissue Allografts Market Report Soft Tissue Allografts Market Size and Share Soft Tissue Allografts Market Scope and Analysis

Soft Tissue Allografts Market Report Scope

Report Attribute Details
Market size in 2024 US$ 4,088.49 Million
Market Size by 2031 US$ 6,748.28 Million
Global CAGR (2024 - 2031) 7.4%
Historical Data 2021-2023
Forecast period 2024-2031
Segments Covered By Type
  • Cartilage Allograft
  • Tendon Allograft
  • Dental Allograft
  • Meniscus Allografts
  • Placental Tissue
By Application
  • Orthopedic
  • Dentistry
  • Wound Care
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Zimmer Biomet Holdings Inc
  • Conmed Corp
  • Stryker Corp
  • Smith Nephew Plc
  • Integra LifeSciences Holdings Corp
  • Arthrex Inc
  • AbbVie Inc
  • Organogenesis Inc
  • Dentsply Sirona Inc
  • Axogen Corporation
    		•

    Soft Tissue Allografts Market News and Recent Developments

    The soft tissue allografts market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below are a few of the key development witnessed in the soft tissue allografts market:

    • Dentsply Sirona updated its Symbios Allograft product line to emphasize enhanced sterility and versatility. The enhanced Symbios Allograft line offers both mineralized and demineralized regenerative solutions, tailored for various dental surgery and implant needs. These products are designed to promote bone formation, increase volume, and ensure stability for predictable, long-term outcomes. The updated portfolio features new granule allografts, putty products, and the acellular dermal matrix known as Symbios PerioDerm. (Source: Dentsply Sirona, July 2024)
    • Axogen, Inc. launched its latest product, Avive+ Soft Tissue Matrix. This resorbable, multi-layer amniotic membrane allograft acts as a soft tissue barrier, providing temporary protection and separation during the critical healing phase of peripheral nerve injuries. Avive+ meets US FDA requirements for Human Cellular and Tissue-based Products under Part 1271 regulations and complies with state regulations as a 361 human tissue product. (Source: Axogen, Inc., Press Release, June 2024)

    Soft Tissue Allografts Market Report Coverage and Deliverables

    The "Soft Tissue Allografts Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Soft tissue allografts market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Soft tissue allografts market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Soft tissue allografts market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the soft tissue allografts market
    • Detailed company profiles